Evidence map›Paper›PMID 41232373›Full record

ArticleComputers in biology and medicine2025

Monte Carlo Tree Search for optimal cancer intervention strategies among BRCA mutation carriers.

Wuyang Qian, Suhao Chen, Bing Yao

Abstract read
In one paragraph

Article in Computers in biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wuyang QianDepartment of Industrial Engineering, South Dakota School of Mines and Technology, 501 East Saint Joseph Street, Rapid City, SD 57701, USA. Electronic address: wuyang.qian@mines.sdsmt.edu.
Suhao ChenDepartment of Industrial Engineering, South Dakota School of Mines and Technology, 501 East Saint Joseph Street, Rapid City, SD 57701, USA. Electronic address: suhao.chen@sdsmt.edu.
Bing YaoDepartment of Industrial and Systems Engineering, The University of Tennessee, 851 Neyland Drive, Knoxville, TN 37996, USA. Electronic address: byao3@utk.edu.

Funding

SCH: Simulation Optimization of Cardiac Surgical PlanningR01HL172292 · NHLBI · UNIVERSITY OF TENNESSEE KNOXVILLE · PI Hui Yang, Bing Yao · 2023 to 2026
$1.2M
NHLBI NIH HHS R01 HL172292
6 · The paper itself

Abstract

Breast and ovarian cancers are the second and fifth leading causes of cancer-related death among women in the United States. Compared to non-carriers, BRCA mutation carriers are subject to a higher risk of developing breast and ovarian cancers. Prophylactic surgeries including prophylactic mastectomy and prophylactic bilateral salpingo-oophorectomy can significantly reduce the incidence risks of breast and ovarian cancers for BRCA mutation carriers. However, both prophylactic surgeries are permanent one-time interventions. Determining the optimal age for BRCA carriers to undergo such surgeries is critical. The optimal solution depends on sequential decision-making over long periods during a patient's life involving the cancer incidence risk and quality of life (QOL). Thus, there is an urgent need to develop an optimal cancer intervention strategy with the goal to reduce cancer risk and maintain a high-level QOL. This paper presents a novel sequential decision-making framework for BRCA mutation carriers by jointly considering the two objectives. We first propose to model the dynamic progression of cancer risk using a continuous-time Markov Decision Process. Second, we propose to solve for the optimal intervention strategies through Monte Carlo Tree Search (MCTS) by optimally balancing the exploitation of current knowledge and exploration of uncertainty factors about the cancer state. Experimental results show that the proposed MCTS planning method can effectively provide optimal sequential intervention strategies for BRCA mutation carriers, reducing the risk of cancer incidence while maintaining a high-level QOL.

Indexed as

BRCA1 ProteinBRCA2 ProteinBreast NeoplasmsMonte Carlo MethodMutationOvarian NeoplasmsFemaleHeterozygoteHumansQuality of LifeBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanBreast cancerCancer interventionContinuous-time Markov decision processMonte Carlo Tree SearchOvarian cancer

Identifiers

PMID41232373
PMCPMC13372348

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.